Loading...
Tositumomab and Iodine I 131 Tositumomab (Bexaar)
Tositumomab and iodine I 131 tositumomab (Bexaar) therapeutic regimen targets monoclonal antibodies against the CD20 antigen expressed in non-Hodgkin lymphoma. This article reviews the mechanism of action and clinical indications for this regimen.
Saved in:
| Published in: | AJNR Am J Neuroradiol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society of Neuroradiology
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7965875/ https://ncbi.nlm.nih.gov/pubmed/21436340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2593 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|